Clinical Trial: Pharmacokinetic (PK) Evaluation of Nalmefene Formulations
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Opioid Overdose
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Open Label, Randomized, Single Dose, Three-Period Crossover Study in Healthy Subjects to Compare the Pharmacokinetic Profiles of Nalmefene Following Administration of Intravenous and Intram
Brief Summary:
This study is designed to characterize the PK of nalmefene following IV bolus and IM injections using nalmefene 0.5 mg (0.94% MgCl2) and IV bolus of 0.5 mg nalmefene hydrochloride injection in healthy subjects.
Read more